Incorporating Risk Factors to Identify the Indication of Post-mastectomy Radiotherapy in N1 Breast Cancer Treated with Optimal Systemic Therapy: A Multicenter Analysis in Korea (KROG 14-23).
- Author:
Hae Jin PARK
1
;
Kyung Hwan SHIN
;
Jin Ho KIM
;
Seung Do AHN
;
Ja Young KIM
;
Won PARK
;
Yong Bae KIM
;
Yeon joo KIM
;
Jin Hee KIM
;
Kyubo KIM
;
Kyung Ran PARK
;
Hyun Soo SHIN
;
Bae Kwon JEONG
;
Sun Young LEE
;
Suzy KIM
Author Information
- Publication Type:Meta-Analysis ; Multicenter Study ; Original Article
- Keywords: Breast neoplasms; Post-mastectomy radiotherapy; Risk factors
- MeSH: Breast Neoplasms*; Breast*; Follow-Up Studies; Humans; Korea*; Lymph Nodes; Mastectomy; Multivariate Analysis; Neoplasm Metastasis; Radiotherapy*; Recurrence; Retrospective Studies; Risk Factors*
- From:Cancer Research and Treatment 2017;49(3):739-747
- CountryRepublic of Korea
- Language:English
- Abstract: PURPOSE: In a recent meta-analysis, post-mastectomy radiotherapy (PMRT) reduced any first recurrence (AFR) and improved survival in N1 and N2 patients. We investigated risk factors for AFR in N1 after optimal systemic therapy without PMRT, to define a subgroup of patients who may benefit from PMRT. MATERIALS AND METHODS: One thousand three hundred eighty-two pT1-2N1M0 breast cancer patients treated with mastectomy without PMRT between 2005 and 2010 were retrospectively analyzed. Only 0.6% had no systemic therapy. RESULTS: After a median follow-up of 5.9 years, there were 173 AFR (53 loco-regional recurrence [LRR] without distant metastases [DM], 38 LRR with DM, and 82 DM without LRR). The 5-year LRR and AFR rates were 6.1% and 12.0%, respectively. Multivariate analysis revealed that close resection margin (p=0.001) was the only independent risk factor for LRR. Multivariate analysis for AFR revealed that age < 35 years (p=0.025), T2 stage (p=0.004), high tumor grade (p=0.032), close resection margin (p=0.035), and triple-negative biological subtype (p=0.031) were independent risk factors. Two or three positive lymph nodes (p=0.078) were considered a marginally significant factor. When stratified by these six factors, the 5-year LRR rates were 3.6% with 0-1 (n=606), 7.5% with 2-3 (n=655), and 12.7% with 4-6 (n=93) risk factors. The 5-year AFR rates were 7.1% with 0-1, 15.0% with 2-3, and 24.5% with 4-6 risk factors. CONCLUSION: Patients with pT1-2N1M0 breast cancer who underwent mastectomy and optimal systemic therapy showed excellent loco-regional control and disease control. The patients with four or more risk factors may benefit from PMRT, and those with two or three risk factors merit consideration of PMRT.
